The big lie continues.....
"Nemaura Medical Inc (NASDAQ:NMRD) revealed with second-quarter results on Monday that it was executing aggressively on its commercial strategy for SugarBEAT, the world’s first painless glucose monitor.
Nemaura launched shipments of its SugarBEAT continuous glucose monitors to patients in August in the UK. The wave of shipments is Nemaura’s first foray into the European market after receiving its CE ark, an EU seal of approval, in May."
How can Nemaura launch into Europe when DBE has the rights to Europe? And DBE's website is not excepting orders.
Why are the sales not recorded on the just released 10Q?
Why did they not disclose the number of units sold?
Again, this fake press release is designed to prop up the SP with double talk meant to misinform.
News 
Market Data 
Discover 
